PC-002 (Sepantronium Bromide) Enhances the Antitumor Efficacy of Anti-CD20 Antibody By CD20 Upregulation

被引：0

作者：

Jiang, Vernon ^{[1
]}

Li, Xiang ^{[1
]}

He, Na ^{[1
]}

Lv, Yan ^{[1
]}

Wang, Haiyue ^{[1
]}

Zhang, Ming ^{[1
]}

Zhai, Heiyan ^{[1
]}

Yang, Zhen ^{[1
]}

Yang, Yi ^{[1
]}

Guo, Dagang ^{[1
]}

Cao, Zhixiang ^{[1
]}

Chen, Yiyou ^{[1
]}

机构：

[1] Cothera Biosci, San Mateo, CA USA

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-209648

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：5822 / 5823

页数：2

共 50 条

[21] Ofatumumab: a novel monoclonal anti-CD20 antibody
Lin, Thomas S.
PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 51 - 59
[22] Anti-CD20 antibody wows in multiple sclerosis
Cormac Sheridan
Nature Biotechnology, 2015, 33 : 1215 - 1216
[23] The safety and efficacy of the biosimilar anti-CD20 antibody, Truxima, in haematological malignancy
Lo, I.
Bansal, S.
Arami, S.
LEUKEMIA RESEARCH, 2018, 73 : S51 - S51
[24] Anti-CD20 monoclonal antibody/thalidomideMyeloproliferative disorder in an elderly patient (first report with anti-CD20 monoclonal antibody): case report
Reactions Weekly, 2001, 855 (1) : 7 - 7
[25] MAb therapy: the use of anti-CD20 Abs - Therapeutic uses of MAbs directed against CD20
Vose, JM
CYTOTHERAPY, 2000, 2 (06) : 455 - 461
[26] TG20, a Transgenically-Derived Anti-CD20 Monoclonal Antibody, Exhibits Enhanced Cytotoxicity Against Cells with Low Levels of CD20
Echelard, Yann
Pollock, Daniel P.
De Coupade, Catherine
Olivier, Aurelie Groseil
Brune, Frederique
Chen, LiHow
Masiello, Nicholas C.
Williams, Jennifer L.
Gavin, William G.
Chtourou, Sami
Meade, Harry M.
BLOOD, 2011, 118 (21) : 1174 - 1174
[27] Molecular mechanisms of the antitumor effects of anti-CD20 antibodies
Winiarska, Magdalena
Glodkowska-Mrowka, Eliza
Bil, Jacek
Golab, Jakub
FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 277 - 306
[28] Anti-CD20 in lupus
Isenberg, DA
Leandro, MJ
Ehrenstein, MR
Edwards, JCW
Manson, J
Cambridge, G
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 27 - 28
[29] Statins impair antitumor effects of CD20 mAb by inducing conformational changes of CD20
Golab, Jakub
Winiarska, Magdalena
Bil, Jacek
Wilczek, Ewa
Wilczynski, Grzegorz
Lekka, Malgorzata
Engelberts, Patrick J.
Mackus, Wendy J. M.
Stoklosa, Tomasz
Nowis, Dominika
Makowski, Marcin
Glodkowska, Eliza
Issat, Tadeusz
Mrowka, Piotr
Lasek, Witold
Gorska, Elzbieta
Wasik, Maria
Warzocha, Krzysztof
Sinski, Maciej
Gaciong, Zbigniew
Dabrowska-Iwanicka, Anna
Jakobisak, Marek
Parren, Paul W. H. I.
BLOOD, 2007, 110 (11) : 692A - 692A
[30] Redistribution of CD20 and Fcγ receptor IIb (CD32b) into lipid rafts is important for internalisation of CD20 upon ligation with type I anti-CD20 mAbs
Vaughan, A. T.
Lim, S. H.
Beers, S. A.
Glennie, M. J.
Cragg, M. S.
IMMUNOLOGY, 2011, 135 : 189 - 189

← 1 2 3 4 5 →